News
Half a million people using weight-loss jabs are at risk of invalidating their travel insurance this summer, experts warn.
Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...
When Amy Schumer realized Ozempic and Wegovy had harmful side effects for her, she didn’t let that deter her from trying other prescriptions to lose ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
A New Zealand bariatric surgeon cautions that Wegovy, a new weight-loss drug, isn't a magic bullet for obesity. While it can trigger initial weight loss, long-term success hinges on lifestyle changes ...
Dr Rowan French insists lasting weight loss can only be achieved through a balanced approach to psychology, exercise and nutrition.
Explore more
The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...
Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...
Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.
The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should see earnings gains through the end of the decade.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results